FDA-cleared K212758
Autoplaque
Cedars-Sinai Medical Center: AIM
Autoplaque is intended to provide an optimized non-invasive application to analyze coronary anatomy and pathology and aid in determining treatment paths from a set of Computed...
- Modality
- CT/CTA
- Anatomy
- Heart/Cardiovascular
- Decision
- 2023-05-19